Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease

被引：29

作者：

Bannai, Ei ^{[1
]}

Yamashita, Hiroyuki ^{[1
]}

Kaneko, Shunta ^{[1
]}

Ueda, Yo ^{[1
]}

Ozaki, Takashi ^{[1
]}

Tsuchiya, Haruka ^{[1
]}

Takahashi, Yuko ^{[1
]}

Kaneko, Hiroshi ^{[1
]}

Kano, Toshikazu ^{[1
]}

Mimori, Akio ^{[1
]}

机构：

[1] Natl Ctr Global Hlth & Med, Div Rheumat Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan

来源：

MODERN RHEUMATOLOGY | 2016年 / 26卷 / 02期

关键词：

Adult-onset Still's disease; Tocilizumab; Macrophage activation syndrome; MACROPHAGE ACTIVATION SYNDROME; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; RECEPTOR ANTIBODY; IL-6; RECEPTOR; EFFICACY; INTERLEUKIN-6; AGENTS; TRIAL;

D O I：

10.3109/14397595.2014.899178

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

To evaluate the effects of tocilizumab (TCZ) on adult-onset Still's disease (AOSD), we reviewed medical records of seven patients with refractory AOSD treated with TCZ at our institution. TCZ therapy might allow rapid corticosteroid tapering and help maintain remission status, that is, resolution of clinical symptoms and normalization of biomarkers such as CRP and ferritin. Patients, however, should be monitored for the development of macrophage activation syndrome when TCZ is administered for active AOSD.

引用

页码：297 / 301

页数：5

共 50 条

[31] Tocilizumab discontinuation after remission achievement in patients with adult-onset Still's disease
Tamai, Hiroya
Kondo, Yasushi
Takeuchi, Tsutomu
Kaneko, Yuko
RHEUMATOLOGY, 2024, : 1437 - 1442
[32] Adult-onset Still?s Disease during Pregnancy Treated with Tocilizumab
Imaizumi, Chihiro
Saito, Masaya
Abe, Fumito
Kaga, Hajime
Saito, Ayano
Nara, Mizuho
Kameyama, Saeko
Miura, Hiroshi
Ogasawara, Hitoshi
Hirakawa, Takeo
Mizunuma, Makito
Satoh, Makiko
Komatsuda, Atsushi
Terada, Yukihiro
Takahashi, Naoto
INTERNAL MEDICINE, 2022, 61 (20) : 3137 - 3140
[33] Efficacy of abatacept in a refractory case of adult-onset Still's disease
Quartuccio, L.
Maset, M.
De Vita, S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : 265 - 267
[34] Therapeutic Efficacy of Leukocytapheresis in a Pregnant Woman with Refractory Adult-onset Still's Disease
Odai, Tsuyoshi
Isozaki, Takeo
Kasama, Tsuyoshi
Ogata, Hiroaki
Kinugasa, Eriko
INTERNAL MEDICINE, 2015, 54 (17) : 2261 - 2266
[35] Treatment of refractory adult onset Still's disease with tocilizumab-a single centre experience and literature review
Reihl Crnogaj, Mirna
Cubelic, Darija
Babic, Antonija
Mayer, Miroslav
Anic, Branimir
RHEUMATOLOGY INTERNATIONAL, 2020, 40 (08) : 1317 - 1325
[36] Successful Treatment of Recurrent Adult-Onset Still's Disease with Tocilizumab: A Case Report and Literature Review
Zhong, Xiaojing
Xu, Tongtong
Li, Tianhao
Luo, Nana
Luo, Nan
Hao, Pingsheng
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 3157 - 3163
[37] Tocilizumab for the treatment of adult-onset Still’s disease: results from a case series
Paola Cipriani
Piero Ruscitti
Francesco Carubbi
Ilenia Pantano
Vasiliki Liakouli
Onorina Berardicurti
Roberto Giacomelli
Clinical Rheumatology, 2014, 33 : 49 - 55
[38] Adult-onset still's disease and treatment results with tocilizumab
Kir, Seher
Ozgen, Metin
Zontul, Sezgin
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (03)
[39] Refractory adult-onset Still disease treated by tocilizumab combined with methotrexate A STROBE-compliant article
Wang, Chun-yan
Guo, Shao-hua
Wang, Li-ping
Shen, Hai-li
MEDICINE, 2019, 98 (32)
[40] Complications of adult-onset Still's disease and their management
Mitrovic, Stephane
Fautrel, Bruno
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (05) : 351 - 365

← 1 2 3 4 5 →